Gilles Salles, MD, PhD, is the Chief of the Lymphoma Service and holds the Steven Greenberg Chair at Memorial Sloan Kettering Cancer Center in New York since 2020. He is also a Professor of Medicine at Weill Cornell Medical College. Previously, he was a Professor of Hematology and Medicine at the University of Lyon and led the Department of Hematology at the Centre Hospitalier Lyon-Sud in France.

Professor Salles earned his PhD in Differentiation, Genetics, and Immunology, along with his medical degree, from Université Claude Bernard Lyon-1. He completed additional training in oncology and worked as a researcher at the Dana-Farber Cancer Institute at Harvard Medical School in Boston, Massachusetts, USA.

Throughout his career, Professor Salles has demonstrated a strong interest in the clinical and biological study of lymphoma. His main focus has been on identifying and validating prognostic factors and designing clinical trials for B-cell lymphomas. He has been involved in researching and developing new therapeutic agents, including several targeted therapies, novel monoclonal antibodies, cellular therapies, and other immunotherapies in the field. He led large international studies evaluating treatment options for patients with follicular and diffuse large B-cell lymphoma. Previously, Professor Salles chaired the Lymphoma Study Association, a European cooperative group. He has served as an Associate Editor for the journal Haematologica since 2021.

Professor Salles has authored over 500 publications, including articles in international peer-reviewed journals such as The New England Journal of Medicine, The Lancet, Cancer Discovery, Blood, Journal of Clinical Oncology, Lancet Oncology, and Haematologica.